Cognetivity Neurosciences Ltd. (CGNSF) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Healthcare Information Services 산업에서 운영. 본사 소재지는 Vancouver, BC, 캐나다. 현재 CEO는 Sina Habibi.
CGNSF 을(를) 보유 IPO 날짜 2021-01-08, 2,500 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $8.96K.
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
